HP
Hemalatha Paisakka
About Hemalatha Paisakka
Data last updated:
Hemalatha Paisakka is a Director at Hexafab Technologies Private Limited (since 2023) and Director at Exentia Pharmaceuticals Private Limited (since 2023). The companies operate in Metals and Minerals and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹41.6 Lakh; the largest is Hexafab Technologies Private Limited at ₹31.4 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hexafab Technologies Private Limited U28998TG2019PTC134476 | Director | 30 May 2023 | 2019 | ₹31.4 Lakh (FY 2023) | Active |
| Exentia Pharmaceuticals Private Limited U52602TG2018PTC124306 | Director | 30 Apr 2023 | 2018 | ₹10.2 Lakh (FY 2023) | Active |
Board colleagues of Hemalatha Paisakka
| Name | DIN | Company | Designation |
|---|---|---|---|
| Yasoda Rani Gantasala | 10198071 | Hexafab Technologies Private Limited | Director |
| Lakshmi Eswar Mohamatam | 10279497 | Exentia Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemalatha Paisakka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemalatha Paisakka
Hemalatha Paisakka currently holds 2 directorships: Hexafab Technologies Private Limited (Director, since 30 May 2023, revenue ₹31.4 Lakh (FY 2023)); Exentia Pharmaceuticals Private Limited (Director, since 30 Apr 2023, revenue ₹10.2 Lakh (FY 2023)).
Hemalatha Paisakka was first appointed on 30 Apr 2023 as Director at Exentia Pharmaceuticals Private Limited.
The 2 current companies of Hemalatha Paisakka that report revenue have a combined latest revenue of ₹41.6 Lakh: Hexafab Technologies Private Limited ₹31.4 Lakh (FY 2023); Exentia Pharmaceuticals Private Limited ₹10.2 Lakh (FY 2023).
The current boards of Hemalatha Paisakka's companies include Yasoda Rani Gantasala (Hexafab Technologies Private Limited), Lakshmi Eswar Mohamatam (Exentia Pharmaceuticals Private Limited).